GENEDRIVE PLC Logo

GENEDRIVE PLC

Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.

GDR | IL

Overview

Corporate Details

ISIN(s):
GB00B1VKB244 (+2 more)
LEI:
213800ZYODIRZ87Y4K14
Country:
United Kingdom
Address:
THE INCUBATOR BUILDING, M13 9XX MANCHESTER

Description

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 10:10
New interactive investor hub
English 13.8 KB
2025-12-09 17:00
Agreement of Shareholder Loan
English 16.9 KB
2025-12-08 17:10
Annual Report and Accounts and date of AGM
English 13.1 KB
2025-12-05 08:20
Final Results
English 215.8 KB
2025-12-03 08:35
Notice of Results
English 13.7 KB
2025-12-01 16:30
Block Listing Returns
English 24.2 KB
2025-12-01 08:40
Results presented re. NHS CYP2C19 Genotype Testing
English 20.0 KB
2025-11-27 11:20
NHS implementation guide published for CYP2C19
English 16.9 KB
2025-11-26 08:25
Scotland national roll-out of MT-RNR1 ID Kit
English 15.3 KB
2025-11-19 08:25
Further re Shareholder Loan
English 17.3 KB
2025-11-04 08:30
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
English 14.8 KB
2025-10-31 08:00
Potential Shareholder Loan
English 13.2 KB
2025-10-24 17:30
Application for Listing & Total Voting Rights
English 12.6 KB
2025-10-10 14:32
Holding(s) in Company
English 52.5 KB
2025-10-10 14:31
Holding(s) in Company
English 23.9 KB

Automate Your Workflow. Get a real-time feed of all GENEDRIVE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEDRIVE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEDRIVE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.